GlassScriptPhysician profile
William T Dowling
NPI 1407808991
$13,145.45
in general payments reported to CMS, 2019-2025
54 companies · $1,909 in 2025
The $1,909 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $435 · 2021: $1,211 · 2022: $2,008 · 2023: $4,711 · 2024: $2,065 · 2025: $1,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,053 · Travel and Lodging: $1,519 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112 · Education: $1.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,052.75 |
| Travel and Lodging | $1,519.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
| Education | $1.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sn Holdings, LLC | $2,226.00 | 2023 | |
| Sumitomo Pharma America, INC. | $1,067.53 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $1,035.41 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $761.11 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $759.61 | 2019-2025 | |
| Dornier Medtech America, INC | $615.65 | 2023 | Dornier Medtech |
| Dendreon Pharmaceuticals LLC | $521.94 | 2019-2025 | Provenge |
| Urovant Sciences INC | $472.49 | 2021-2022 | |
| Antares Pharma, INC. | $463.98 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $432.85 | 2019-2023 | Myrbetriq, Xtandi |
| Progenics Pharmaceuticals, INC. | $418.55 | 2021-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $375.66 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $361.28 | 2019-2024 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $349.86 | 2019-2022 | |
| Tolmar, INC. | $283.47 | 2023-2025 | Jatenzo, Eligard |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $223.04 | 2019-2022 | |
| Olympus America INC. | $189.76 | 2021-2024 | Itind System |
| Urogen Pharma, INC. | $182.58 | 2021-2025 | |
| Procept Biorobotics Corporation | $156.67 | 2021 | |
| Merck Sharp & Dohme LLC | $149.23 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Boston Scientific Corporation | $148.20 | 2021-2025 | Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Amgen INC. | $143.10 | 2019-2023 | Xgeva |
| Teleflex LLC | $140.14 | 2024 | Urolift |
| Ferring Pharmaceuticals INC. | $137.06 | 2019-2025 | Adstiladrin |
| Immunitybio, INC. | $135.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $131.51 | 2024-2025 | |
| Medtronic, INC. | $115.50 | 2023 | Interstim |
| Janssen Scientific Affairs, LLC | $112.01 | 2019-2021 | |
| Endo USA, INC. | $110.54 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $94.47 | 2021-2022 | |
| Blue Earth Diagnostics | $91.02 | 2019-2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $80.08 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $78.80 | 2025 | |
| Foundation Medicine, INC. | $74.90 | 2022-2023 | Foundationone Cdx, Foundationone Liquid Cdx |
| Rochester Medical Corporation | $59.19 | 2021 | |
| 180 Medical, INC. | $53.85 | 2021-2025 | Gentlecath |
| Abc Home Medical Supply, INC. | $53.19 | 2024 | |
| Halozyme INC | $43.39 | 2023 | |
| Accord Healthcare, INC. | $37.17 | 2024 | |
| Convatec INC. | $33.98 | 2021-2022 | |
| Coloplast Corp | $26.40 | 2024 | |
| Mission Pharmacal Company | $25.60 | 2019-2022 | |
| Neotract INC. | $24.18 | 2019 | |
| Cook Medical LLC | $21.59 | 2025 | Litho 150 |
| Clarus Therapeutics INC. | $21.20 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $18.21 | 2023 | Bard Urinary Drainage Bag |
| Zyla Life Sciences, INC. | $16.67 | 2019 | |
| Tempus Ai, INC | $15.96 | 2024 | Xt Cdx |
| Dentsply Ih INC. | $14.90 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.88 | 2022 | |
| Photocure INC | $13.94 | 2025 | Cysview |
| Clovis Oncology, INC. | $11.98 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.